Cullinan Oncology, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ACET
Adicet Bio, Inc. |
$1.09 | $110.93 M | -0.46 | 143 | $0 |
![]() AUTL
Autolus Therapeutics plc |
$2.60 | $1.06 B | -3.31 | 463 | $1.70 M |
![]() BOLT
Bolt Biotherapeutics, Inc. |
$0.62 | $29.02 M | -0.46 | 100 | $7.88 M |
![]() CCCC
C4 Therapeutics, Inc. |
$4.09 | $320.64 M | -1.97 | 110 | $20.76 M |
![]() DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
![]() EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() IPSC
Century Therapeutics, Inc. |
$1.05 | $244.54 M | -1.32 | 152 | $2.24 M |
![]() LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
![]() LYEL
Lyell Immunopharma, Inc. |
$0.68 | $619.50 M | -2.7 | 224 | $61,000 |
![]() LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.56 M |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
![]() OLMA
Olema Pharmaceuticals, Inc. |
$5.50 | $734.41 M | -6.56 | 87 | $0 |
![]() RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
![]() SANA
Sana Biotechnology, Inc. |
$1.75 | $1.55 B | -4.59 | 328 | $0 |
![]() TALS
Talaris Therapeutics, Inc. |
$2.72 | $116.44 M | -1.56 | 84 | $0 |
![]() THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
![]() VOR
Vor Biopharma Inc. |
$1.74 | $83.62 M | -0.69 | 168 | $0 |
![]() ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.13 | $754.16 M | -3.26 | 124 | $0 |